The Role of HF (Factor XII) in the Pathogenesis of the Thrombolytic State Induced by Venous Occlusion^[*]

Summary

The effect of venous occlusion of the forearm on clotting and fibrinolysis was studied on 17 normal subjects. A post-occlusion increase in AHF (factor (VIII) and HF (factor XII) was noted. Fibrinolytic activity, as measured by euglobulin lysis time, plasma plate method, unheated fibrin plate method and plasminoplastin generation test, increased significantly in most of the subjects. A plasma lysokinase (indirect activator) seems to preponderate; this was also accompanied by some plasminoplastin (direct activator) activity. Low concentrations of ε-ACA and ATPase had an inhibitory effect upon the increased lytic activity. The data suggest that the post-occlusion lytic activity which was characterized to be of the lysokinase-type was intimately related to HF (factor XII).

• References

• 1 Biggs R, Macfarlane R. G, Piling J. Observations on Fibrinolysis. Experimental activity produced by exercise or adrenalin. Lancet I: 402 1947;
• 2 Iatridis S. G, Ferguson J. H. Effect of physical exercise on blood clotting and fibrinolysis. J. appl. Physiol 18: 337 1963;
• 3 Macfarlane R. G, Biggs R. Observations on fibrinolysis spontaneous activity associated with surgical operations, trauma, etc. Lancet II: 862 1946;
• 4 Clarke R. L, Orandi A, Cliffton E. E. Induction of fibrinolysis by venous obstruction. Angiology 11: 367 1960;
• 5 Holemans R, Roberts H. R. Hageman factor and in vivo activation of fibrinolysis. J. Lab. clin. Med 64: 778 1964;
• 6 Iatridis S. G, Ferguson J. H. A two-stage assay method for Hageman factor activity. Thrombos. Diathes. haemorrh. (Stuttg.) 8: 46 1962;
• 7 Iatridis S. G, Ferguson J. H. The plasma plate method for estimating thrombolytic activity. Proc. Soc. exp. Biol. (N. Y.) 110: 738 1962;
• 8 Iatridis S. G, Ferguson J. H. Active Hageman factor: A plasma lysokinase of the human fibrinolytic system. J. clin. Invest 41: 1277 1962;
• 9 Alkjaersig N, Fletcher A. P, Sherry S. E-Aminocaproic acid: an inhibitor of plasminogen activation. J. biol. Chem 238: 832 1959;
• 10 Sawyer W. D, Fletcher A. P, Alkjaersig N, Sherry S. Studies on the thrombolytic activity of human plasma. J. clin. Invest 39: 426 1960;
• 11 Iatridis P. G, Ferguson J. H. ATP-ase as an in vitro inhibitor of Surface factor in the blood clotting mechanism. Proc. Soc. exp. Biol. (N. Y.) 118: 647 1965;
• 12 Iatridis S. G, Ferguson J. H. Effects of surface and Hageman factor on the endogenous or spontaneous activation of the fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg.) 15: 411 1961;
• 13 Iatridis S. G. Fibrinolysis and intravascular coagulation - Separate or associated Mechanism (Trans. St. Moritz Conf. 1965) Thrombos. Diathes. haemorrh. (Stuttg.), Suppl. (In press.)
• 14 Stafford J. L. Fibrinolysis and intrinsic haemostasis. Brit. med. Bull 20: 179 1964;
• 15 Eisen V. Fibrinolysis and formation of biologically active polypeptides. Brit. med. Bull 20: 205 1964;
• 16 Egeberg O. The effect of venous congestion on the blood clotting system. Scand. J. clin. Lab. Invest 15: 20 1962;
• 17 Iatridis P. G, Iatridis S. G, Ferguson J. H. ATP-ase as Inhibitor of Lysokinase and Plasminoplastin Activators of Fibrinolysis in vitro. Proc. Soc. exp. Biol. (N. Y.) 121: 788 1966;
• 18 Kwaan H. G, Lo R, McFadjean A. J. S. Lysis of thrombi experimentally produced within veins. Brit. J. Haematol 4: 51 1958;